Skip to main content
Header logo
  • About Moberg Open link menu
    About Moberg
    • CEO Comments
    • Business Model
    • Board and Leadership
  • MOB-015
  • Sustainability
  • Investors Open link menu
    Investors
    • Results and Presentations
    • The share Open link menu
      The share
      • Major shareholders
      • Insider Trading
      • Financial Data
    • Analysts
    • Calendar
    • Corporate governance Open link menu
      Corporate governance
      • Board of directors
      • Management
      • General shareholders meetings
      • Nomination committee
      • Auditors
      • Remuneration
      • Share-based incentive program
      • Articles of Association
    • Press releases
    • Prospectus
  • Media Open link menu
    Media
    • Image Archive
    • Press Releases
  • Contact
    • EN Current language English, click to switch language
    • SV Switch to Swedish
  • Please fill out this field
Close
Please fill out this field
Press Releases
Breadcrumbs
  • Home
  • Media
  • Press Releases

Press Releases

Press Releases Regulatory Press Releases
More
Press Releases Data
2019-02-11 18:00
Moberg Pharma and Bayer sign exclusive license agreement for MOB-015 in Europe
Read more
2019-02-05 08:30
Moberg Pharma's Year-end report to be published on February 12 - Invitation to teleconference
Read more
2019-01-08 08:30
Moberg Pharma appoints members to the Management team
Read more
2018-11-23 08:30
Patent granted for MOB-015 in China
Read more
2018-11-08 08:30
Moberg Pharma's nomination committee appointed
Read more
2018-11-06 08:00
Moberg Pharma AB Interim report January - September 2018
Read more

Pagination

  • First page
  • Previous page
  • …
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Current page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • …
  • Next page
  • Last page
Press Releases Data
2017-04-11 08:30
Moberg Pharma Annual Report 2016
Read more
2017-04-06 08:30
The Nomination Committee's proposal to the Annual General Meeting 2017
Read more
2017-03-30 08:30
Nationwide launch in Japan
Read more
2017-02-14 08:00
Moberg Pharma AB Year-end report 2016
Read more
2017-01-18 08:30
Moberg Pharma expands New Skin retail presence
Read more
2016-12-31 08:30
Moberg Pharma completes acquisition of DermoPlast from Prestige Brands
Read more

Pagination

  • First page
  • Previous page
  • …
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Current page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • …
  • Next page
  • Last page
What we do

Moberg Pharma AB
Telephone: 08-522 307 00
Email: [email protected]

Mailing Address: 
Gustavslundsvägen 42, 167 51 Bromma
Visiting Address: 
Gustavslundsvägen 50, 167 51 Bromma

Sign up to receive our press releases and reports.

Sign up

Home
Moberg Pharma´s Interim report January - September 2024

Footer

  • Sitemap
  • Privacy Policy
  • Terms of Use
  • Cookies
  • Copyright
  • Cookie settings
  • © Moberg Pharma AB (publ) 2026